| __timestamp | Ligand Pharmaceuticals Incorporated | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 14182353 |
| Thursday, January 1, 2015 | 13380000 | 15503028 |
| Friday, January 1, 2016 | 21221000 | 16183585 |
| Sunday, January 1, 2017 | 26887000 | 22382849 |
| Monday, January 1, 2018 | 27863000 | 33038206 |
| Tuesday, January 1, 2019 | 55908000 | 31777040 |
| Wednesday, January 1, 2020 | 59392000 | 41464134 |
| Friday, January 1, 2021 | 69012000 | 67178053 |
| Saturday, January 1, 2022 | 36082000 | 52531000 |
| Sunday, January 1, 2023 | 24537000 | 68914000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, innovation is the key to staying ahead. This analysis compares the research and development (R&D) spending of two prominent companies: Pharming Group N.V. and Ligand Pharmaceuticals Incorporated, from 2014 to 2023. Over this period, Pharming Group N.V. has shown a consistent increase in R&D investment, peaking in 2023 with a 386% increase from its 2014 spending. Ligand Pharmaceuticals, while also increasing its R&D budget, saw a more fluctuating trend, with a notable peak in 2021, where spending was 469% higher than in 2014. This data highlights the strategic emphasis each company places on innovation, with Pharming Group N.V. demonstrating a steady commitment and Ligand Pharmaceuticals showing a more variable approach. As the pharmaceutical landscape continues to change, these investments in R&D will likely play a crucial role in shaping the future of healthcare.
Comparing Innovation Spending: Johnson & Johnson and Pharming Group N.V.
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
R&D Spending Showdown: Pharming Group N.V. vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending